Since adipose tissue from different depots makes different contributions to the pathogenesis of obesity and the characteristics of the response to therapy [16], it is of interest to assess the levels of lncRNA H19 in SAT and VAT depots as well as in plasma. This evidence concerns the gene H19 and obesity due to melanocortin 4 receptor deficiency.